NCT06625749
Evaluate the Safety and Effectiveness of the AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery
At risk: Primary completion moved at least 1 year 8 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Mar 2026 to Dec 2027
- Eligibility criteria expanded, about 61 words
- Primary endpoints: details revised at 1 of 1 entry
- Trial status changed: Unknown → Recruiting
- Minor Changed Registry marked status Unknown; last known: Recruiting
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Improvement in uncorrected near visual acuity (UCNVA) at 40 cm/16 inches
Timeframe: 12 months
Arms and interventions
AccuraSee™ intraocular pseudophakic capsular lens (IOPCL)Experimental
Devices: Accurasee™ IOPCL
Sites
1 site in 1 country
- Midwest Vision PartnersCleveland, Ohio, United States